YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner.

Tan, Chunzhong; Xia, Peng; Zhang, Hao; Xu, Kequan; Liu, Pengpeng; Guo, Deliang; Liu, Zhisu

Tan, Chunzhong; Xia, Peng; Zhang, Hao; Xu, Kequan; Liu, Pengpeng; Guo, Deliang; Liu, Zhisu.

Afiliação

Tan C; Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xia P; Department of Translational Medicine Research Center, Wuhan University, Wuhan, China.
Zhang H; Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xu K; Department of Translational Medicine Research Center, Wuhan University, Wuhan, China.
Liu P; Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Guo D; Department of Translational Medicine Research Center, Wuhan University, Wuhan, China.
Liu Z; Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Front Oncol ; 12: 873020, 2022.

Article em En | MEDLINE | ID: mdl-35494016

Palavras-chave

N6-methyladenosine; RBM15B; TRAM2; hepatocellular carcinoma; mRNA stability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google